EGFR and lung adenocarcinoma: The data indicated that the CD44 rs11821102 G/A polymorphism might influence unique microRNA, thereby altering specific CD44 mRNA subtypes in male patients with lung adenocarcinoma harboring the EGFR L858R mutation.